Search Results 3161-3170 of 42576 for oral

  1. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  2. Osteomyelitis - Doctors and departments - Mayo Clinic

    Kyle S. Ettinger, M.D., D.D.S.. Surgical Oncologist; Oral and Maxillofacial Surgeon. Rochester, MN ...

  3. Drugs and Supplements that Start with B - Mayo Clinic

    Basic Care Mini Nicotine Polacrilex Lozenge - Mint. Also known as. Nicotine (oral route, oromucosal route). Basic Care Stool Softener. Also known as.

  4. Sarcoma - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgeon. Rochester, MN. Areas of focus: Cancer treatment, Tracheostomy, Jaw surgery, Flap surgery, Cancer rehabilitation, Skin biopsy ...

  5. Sarcoma - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgeon. Rochester, MN. Areas of focus: Cancer treatment, Tracheostomy, Jaw surgery, Flap surgery, Cancer rehabilitation, Skin biopsy ...

  6. Skin cancer - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Microvascular surgery, Skull base surgery, Skin cancer reconstruction, Submandibular gland removal, Radial forearm free flap, Oral cancer ...

  7. Drugs and Supplements that Start with C - Mayo Clinic

    C-Time w/Rose Hips. Also known as. Ascorbic acid (oral route). Back to top. C1. C1 esterase inhibitor recombinant (intravenous route).

  8. Drugs and Supplements that Start with M - Mayo Clinic

    Ma · Maalox Anti-Gas. Also known as. Simethicone (oral route) · Macimorelin (oral route) · Macitentan (oral route) · Macitentan and tadalafil (oral route) · Macrilen.

  9. Heat rash - Diagnosis & treatment - Mayo Clinic

    Learn more about the symptoms, causes and treatment of this heat-related problem of the skin that affects people of all ages.

  10. Fecal Microbiota (Stool) Transplant Clinical Trials - Mayo Clinic Research

    ... oral antibiotic therapy or have had at least two episodes of severe CDI resulting in hospitalization may be eligible for the study. Subjects may receive a ...